Monday 2 November 2026
Export RYAM’s income statement to Excel — free account
Rayonier Advanced Materials Inc.
RYAM Basic Materials Chemicals
Rayonier Advanced Materials Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 10.1% from fiscal 2024.
- Revenue
- +10.6%
- EPS
- +91.0%
- Free cash flow
- +69.9%
- Total debt
- +3.90%
Quarter to June 2026, against a year earlier
6.66
0.05
+0.76%
Follow RYAM
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.33 | 0.27 | 0.52 | 0.36 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(27.20) | 12.19 | 23.27 | 106.04 | |
P/B ratio |
1.43 | 1.24 | 3.24 | 2.72 | |
Price to Tangible BV |
1.45 | 1.26 | 3.29 | 2.78 | |
EV/Sales |
0.82 | 0.75 | 1.00 | 0.85 | |
EV/EBITDA |
8.36 | 7.48 | 14.59 | 13.23 | |
EV/Operating CF |
25.77 | 45.88 | 88.63 | 24.28 | |
EV/FCF |
(14.93) | (11.96) | (17.16) | (34.15) | |
Quick Ratio |
0.70 | 0.75 | 0.63 | 0.64 | |
Current Ratio |
1.57 | 1.58 | 1.37 | 1.37 | |
Net Debt/EBITDA |
16.71 | 12.19 | (21.83) | 27.98 | |
Debt/Assets |
44.19% | 44.30% | 45.79% | 47.83% | |
Debt/Equity |
2.35 | 2.46 | 3.33 | 3.98 | |
Asset Turnover |
0.74 | 0.75 | 0.76 | 0.87 | |
Operating CF/Net income |
3.99 | (1.47) | (0.39) | (0.15) | |
Capex/Depreciation |
(0.71) | (0.36) | (0.66) | (0.79) | |
Interest Coverage |
0.39 | 0.42 | (2.83) | (0.26) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.70% | 4.53% | 6.01% | 4.58% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.41% | 0.19% | 0.24% | 0.22% | |
Graham Net Nets |
(1.79) | (2.22) | (1.22) | (1.72) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(86.57%) | (107.30%) | (63.69%) | (26.72%) | |
Free Cash Flow Yield |
(16.62%) | (23.31%) | (11.28%) | (6.89%) | |
Revenue per Share |
5.27 | 6.30 | 4.75 | 5.57 | |
Operating CF per Share |
(0.27) | 0.48 | 0.48 | 0.07 | |
Capex per Share |
(0.35) | (0.25) | (0.33) | (0.38) | |
Free Cash Flow per Share |
(0.62) | 0.23 | 0.15 | (0.30) | |
Cash per Share |
1.15 | 1.13 | 1.01 | 0.84 | |
Shareholders Equity per Share |
5.05 | 4.74 | 3.42 | 2.88 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
5.05 | 4.74 | 3.42 | 2.88 | |
Free Cash Flow |
(41.48) | 15.33 | 9.93 | (20.35) | |
Working Capital |
214.37 | 208.01 | 144.02 | 138.62 | |
Capital Expenditures |
(23.69) | (16.93) | (22.00) | (25.35) | |
Net Current Asset Value |
(867.29) | (873.42) | (908.79) | (914.63) | |
EV/EBIT |
278.18 | 267.69 | 0.00 | 0.00 | |
Capex to Sales |
0.07 | 0.04 | 0.07 | 0.07 | |
Price to Operating Income |
112.11 | 95.99 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
190.47 | 204.96 | 170.43 | 166.77 | |
Average Payables |
169.53 | 193.35 | 201.15 | 191.73 | |
Average Inventory |
244.02 | 222.99 | 217.88 | 214.59 | |
Average Assets |
1,977.73 | 1,944.01 | 1,892.46 | 1,687.39 | |
Average Common Equity |
535.46 | 515.22 | 458.72 | 268.54 |
Columns are period end dates